Current Pharmaceutical Design
Title: Editorial [Hot Topic: Pharmaceutical and Cellular Strategies of Recent Advances in Immunotherapy (Executive Editors: George Tuszynski and Mahesh Sharma)]
Volume: 15 Issue: 17
Author(s): George Tuszynski and Mahesh Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Tuszynski George and Sharma Mahesh, Editorial [Hot Topic: Pharmaceutical and Cellular Strategies of Recent Advances in Immunotherapy (Executive Editors: George Tuszynski and Mahesh Sharma)], Current Pharmaceutical Design 2009; 15 (17) . https://dx.doi.org/10.2174/138161209788453176
DOI https://dx.doi.org/10.2174/138161209788453176 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rosuvastatin Ameliorates Obesity and Proteinuria in Zucker Diabetic Fatty Rats
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Apoptosis Signaling Pathways in Anticancer Therapy
Current Cancer Therapy Reviews Topical Lipid Based Drug Delivery Systems for Skin Diseases: A Review
Current Drug Therapy The Influenza Virus NS1 Protein: Inhibitor of Innate and Adaptive Immunity
Infectious Disorders - Drug Targets Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design Motility Disorders, Functional Gastrointestinal Disorders, Inflammatory Bowel Disease and Cardiac Rhythm Disturbances - Is there a Link? Review of Literature
Current Drug Targets Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Current Cancer Drug Targets Chemokines and Breast Cancer: A Gateway to Revolutionary Targeted Cancer Treatments?
Current Medicinal Chemistry Endothelial Remodelling and Intracellular Calcium Machinery
Current Molecular Medicine Physiologic Versus Diabetogenic Effects of Interleukin-1: A Question of Weight
Current Pharmaceutical Design Structure, Function and Control of Complement C5 and its Proteolytic Fragments
Current Molecular Medicine Glutathione for Hepatotoxicity in Patients with Liver Cirrhosis and Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy
Clinical Cancer Drugs Chemokines and their Receptors in Gut Homeostasis and Disease
Current Immunology Reviews (Discontinued) Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
Current Drug Targets Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies
Current Neuropharmacology Proteasomes as Drug Targets
Current Drug Targets Non-Analgesic Effects of Opioids: Opioid-induced Nausea and Vomiting: Mechanisms and Strategies for their Limitation
Current Pharmaceutical Design The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs
CNS & Neurological Disorders - Drug Targets